Search Results - "Lonskaya, Irina"

Refine Results
  1. 1

    Ubiquitination increases parkin activity to promote autophagic α-synuclein clearance by Lonskaya, Irina, Desforges, Nicole M, Hebron, Michaeline L, Moussa, Charbel E-H

    Published in PloS one (26-12-2013)
    “…Parkinson's disease (PD) is a movement disorder associated with genetic and age related causes. Although autosomal recessive early onset PD linked to parkin…”
    Get full text
    Journal Article
  2. 2

    Tyrosine kinase inhibition increases functional parkin‐Beclin‐1 interaction and enhances amyloid clearance and cognitive performance by Lonskaya, Irina, Hebron, Michaeline L., Desforges, Nicole M., Franjie, Alexander, Moussa, Charbel E.‐H.

    Published in EMBO molecular medicine (01-08-2013)
    “…Tyrosine kinase inhibitors (TKIs) are effective therapies for leukaemia. Alzheimer is a neurodegenerative disease characterized by accumulation of β‐amyloid…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Tyrosine kinase inhibition reverses TDP‐43 effects on synaptic protein expression, astrocytic function and amino acid dis‐homeostasis by Heyburn, Lanier, Hebron, Michaeline L., Smith, Jacqueline, Winston, Charisse, Bechara, John, Li, Zhaoxia, Lonskaya, Irina, Burns, Mark P., Harris, Brent T., Moussa, Charbel E.‐H.

    Published in Journal of neurochemistry (01-11-2016)
    “…The trans‐activating response of DNA/RNA‐binding protein (TDP)‐43 pathology is associated with many neurodegenerative diseases via unknown mechanisms. Here, we…”
    Get full text
    Journal Article
  5. 5

    Parkin-mediated reduction of nuclear and soluble TDP-43 reverses behavioral decline in symptomatic mice by Wenqiang, Chen, Lonskaya, Irina, Hebron, Michaeline L, Ibrahim, Zainab, Olszewski, Rafal T, Neale, Joseph H, Moussa, Charbel E-H

    Published in Human molecular genetics (15-09-2014)
    “…The transactivation DNA-binding protein (TDP)-43 binds to thousands of mRNAs, but the functional outcomes of this binding remain largely unknown. TDP-43 binds…”
    Get full text
    Journal Article
  6. 6

    Methamphetamine‐associated cleavage of the synaptic adhesion molecule intercellular adhesion molecule‐5 by Conant, Katherine, Lonskaya, Irina, Szklarczyk, Arek, Krall, Caroline, Steiner, Joseph, Maguire‐Zeiss, Kathleen, Lim, Seung T.

    Published in Journal of neurochemistry (01-08-2011)
    “…J. Neurochem. (2011) 118, 521–532. Methamphetamine (MA) is a highly addictive psychostimulant that, used in excess, may be neurotoxic. Although the mechanisms…”
    Get full text
    Journal Article
  7. 7

    Soluble ICAM-5, a product of activity dependent proteolysis, increases mEPSC frequency and dendritic expression of GluA1 by Lonskaya, Irina, Partridge, John, Lalchandani, Rupa R, Chung, Andrew, Lee, Taehee, Vicini, Stefano, Hoe, Hyang-Sook, Lim, Seung T, Conant, Katherine

    Published in PloS one (02-07-2013)
    “…Matrix metalloproteinases (MMPs) are zinc dependent endopeptidases that can be released from neurons in an activity dependent manner to play a role in varied…”
    Get full text
    Journal Article
  8. 8

    Regulation of Poly(ADP-ribose) Polymerase-1 by DNA Structure-specific Binding by Lonskaya, Irina, Potaman, Vladimir N., Shlyakhtenko, Luda S., Oussatcheva, Elena A., Lyubchenko, Yuri L., Soldatenkov, Viatcheslav A.

    Published in The Journal of biological chemistry (29-04-2005)
    “…Poly(ADP-ribose) polymerase-1 (PARP-1) is an intracellular sensor of DNA strand breaks and plays a critical role in cellular responses to DNA damage. In…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of [alpha]-synuclein in Parkinson's disease models by Hebron, Michaeline L, Lonskaya, Irina, Moussa, Charbel E-H

    Published in Human molecular genetics (15-08-2013)
    “…Parkinson's disease is a movement disorder characterized by death of dopaminergic substantia nigra (SN) neurons and brain accumulation of alpha -synuclein. The…”
    Get full text
    Journal Article
  11. 11

    Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies by Liu, Xiaoguang, Hebron, Michaeline, Shi, Wangke, Lonskaya, Irina, Moussa, Charbel E-H

    Published in Human molecular genetics (15-02-2019)
    “…Abstract Ubiquitin specific proteases (USPs) are de-ubiquitinases (DUBs) that control protein ubiquitination cycle. The role of DUBs is poorly understood in…”
    Get full text
    Journal Article
  12. 12

    Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance by Lonskaya, Irina, Hebron, Michaeline L., Desforges, Nicole M., Schachter, Joel B., Moussa, Charbel E-H

    “…Alzheimer's disease (AD) is a neurodegenerative disorder associated with amyloid accumulation and autophagic changes. Parkin is an E3 ubiquitin ligase involved…”
    Get full text
    Journal Article
  13. 13

    Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models by Lonskaya, Irina, Hebron, Michaeline, Chen, Wenqiang, Schachter, Joel, Moussa, Charbel

    Published in Molecular neurodegeneration (10-11-2014)
    “…Tau is an axonal protein that binds to and regulates microtubule function. Hyper-phosphorylation of Tau reduces its binding to microtubules and it is…”
    Get full text
    Journal Article
  14. 14

    Discoidin domain receptor inhibition reduces neuropathology and attenuates inflammation in neurodegeneration models by Hebron, Michaeline, Peyton, Margo, Liu, Xiaoguang, Gao, Xiaokong, Wang, Ruochong, Lonskaya, Irina, Moussa, Charbel E.-H.

    Published in Journal of neuroimmunology (15-10-2017)
    “…The role of cell surface tyrosine kinase collagen-activated receptors known as discoidin domain receptors (DDRs) is unknown in neurodegenerative diseases. We…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Tyrosine kinase inhibition facilitates autophagic SNCA/α-synuclein clearance by Hebron, Michaeline L., Lonskaya, Irina, Moussa, Charbel E.-H.

    Published in Autophagy (01-08-2013)
    “…The effects of ABL1/ABL inhibition on clearance of SNCA/α-synuclein were evaluated in animal models of α-synucleinopathies. Parkinson disease (PD) is a…”
    Get full text
    Journal Article
  19. 19

    Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease by Lonskaya, Irina, Shekoyan, Ashot R, Hebron, Michaeline L, Desforges, Nicole, Algarzae, Norah K, Moussa, Charbel E-H

    Published in Journal of Alzheimer's disease (01-01-2013)
    “…Alzheimer's disease (AD) is an aging disorder characterized by amyloid-β (Aβ) accumulation in extracellular plaques and formation of intracellular tangles…”
    Get more information
    Journal Article
  20. 20

    Parkin reverses TDP‐43‐induced cell death and failure of amino acid homeostasis by Hebron, Michaeline, Chen, Wenqiang, Miessau, Matthew J., Lonskaya, Irina, Moussa, Charbel E.‐H.

    Published in Journal of neurochemistry (01-04-2014)
    “…The E3 ubiquitin ligase Parkin plays a central role in the pathogenesis of many neurodegenerative diseases. Parkin promotes specific ubiquitination and affects…”
    Get full text
    Journal Article